Hyderabad, January 20, 2025: The Apollo University, Apollo Hospitals and University of Leicester, United Kingdom, have partnered to establish the Centre for Digital Health and Precision Medicine (CDHPM) at The Apollo University campus in Chittoor, Andhra Pradesh. The advanced research centre will bring together the expertise and resources of both institutions …
Read More »Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month
Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 million new cases diagnosed annually, contributing to 18% of all cancer-related deaths, according to the International Agency for Research on Cancer. In India, it continues to be a leading cause of cancer-related mortality. However, advancements …
Read More »Three Scientists from Dr. D.Y. Patil Medical College Shine Among Stanford University’s Top 2% Global Researchers for 2024
Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pimpri, Pune, proudly announces that three of its esteemed scientists-Dr. Amitav Banerjee, Professor of Community Medicine, Dr. Sarika Chaturvedi, Senior Scientist and Dr. Sachin Atre, Research Consultant and Adjunct Faculty-have been recognized among the Top 2% Scientists in the World, …
Read More »ICMR and NTPC Join Forces to Enhance Solar Power in Health Research Facilities
In a landmark agreement to promote sustainable energy within India’s healthcare and research sector, aligning with the Hon’ble Prime Minister’s vision of “Atmanirbhar Bharat” (self-reliant India) and a cleaner, greener future, the Indian Council of Medical Research (ICMR) signed a Memorandum of Understanding (MoU) with NTPC Vidyut Vyapar Nigam (NVVN). …
Read More »ICMR Partners with Industry and Academia for First-in-Human Phase 1 Trials
In a significant stride towards strengthening India’s clinical research ecosystem, the Indian Council of Medical Research (ICMR) has formalized Memorandum of Agreements (MoAs) with multiple sponsors under its Network of Phase 1 Clinical Trials. The agreements mark a ground-breaking entry into First-in-Human Clinical Trials for four promising molecules. These include …
Read More »